Wedge Capital Management L L P Veru Inc. Transaction History

Wedge Capital Management L L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$2.58 - $3.36 $759,128 - $988,632	-294,236 Closed	0 $0
Q2 2020 Jul 10, 2020	SELL	$3.01 - $4.02 $109,007 - $145,584	-36,215 Reduced 10.96%	294,236 $983,000
Q1 2020 Apr 13, 2020	BUY	$2.58 - $4.58 $93,509 - $165,997	36,244 Added 12.32%	330,451 $1.08 Million
Q4 2019 Jan 15, 2020	BUY	$1.86 - $3.35 $203,428 - $366,389	109,370 Added 59.17%	294,207 $986,000
Q2 2019 Aug 01, 2019	BUY	$1.26 - $2.14 $232,894 - $395,551	184,837 New	184,837 $394,000

122

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $54.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.